Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Italy Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20033
20054
20062
20073
20085
20097
20105
20115
20122
20132
20144
20152
20173
20195
20204
20214
20223
20233
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Active, not recruiting15
Recruiting11
Terminated7
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Pfizer8
Merck Sharp & Dohme LLC5
Bristol-Myers Squibb4
European Organisation for Research and Treatment of Cancer - EORTC4
Sanofi4
Amgen3
Ferring Pharmaceuticals3
Abbott2
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms81
Neoplasms8
Neoplasm Metastasis7
Urogenital Neoplasms3
Genital Neoplasms, Male2
Pain2
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.